EU Withdrawal Note Substance Human Origin

Brussels, 23 January 2018 NOTICE TO STAKEHOLDERS WITHDRAWAL OF THE UNITED KINGDOM AND EU RULES IN THE FIELD OF SUBSTANCES OF HUMAN ORIGIN (BLOOD, TISSUES AND CELLS, AND ORGANS) The United Kingdom submitted on 29 March 2017 the notification of its intention to withdraw from the Union pursuant to Article 50 of the Treaty on […]

Read More

Medicines UK No Deal Notes

Batch testing medicines Purpose This notice updates businesses on the arrangements that will come into force in the unlikely event that the UK leaves the EU on 29 March 2019 (may also apply to new exit date on 31 December 2020) with no agreement in place for the regulation of human medicines. This notice only covers arrangements with reference to: batch testing, by manufacturers, of human […]

Read More

UK Commons Committee Pharma Sector

Important Notice- See the Disclaimer Below Brexit Legal, McMahon Legal and Paul McMahon have no liability arising from reliance on anything contained in this article nor on this website Contact McMahon Legal  Share this article

Read More

UK Commons Committee Medicine

Important Notice- See the Disclaimer Below Brexit Legal, McMahon Legal and Paul McMahon have no liability arising from reliance on anything contained in this article nor on this website Contact McMahon Legal  Share this article

Read More

UK Commons Committee Health Social Care

Important Notice- See the Disclaimer Below Brexit Legal, McMahon Legal and Paul McMahon have no liability arising from reliance on anything contained in this article nor on this website Contact McMahon Legal  Share this article

Read More

Children’s Services

Brexit: no deal preparations for local authority children’s services in England Advice to local authority children’s services in England on how to prepare in the event that the UK leaves the EU without a deal. Published 15 March 2019 Last updated 19 August 2019 — see all updates From: Department for Education Applies to: England […]

Read More

Health Sector Impact

Important Notice- See the Disclaimer Below Brexit Legal, McMahon Legal and Paul McMahon have no liability arising from reliance on anything contained in this article nor on this website Contact McMahon Legal  Share this article

Read More

Organs Tissues & Cells Guidance

Quality and safety of human organs, tissues and cells if the UK leaves the EU without a deal What you need to do to ensure continued use of human organs, tissues and cells (including reproductive cells) if the UK leaves the EU on 29 March 2019 (may also apply to new exit date on 31 December 2020) without a deal. Published 15 February 2019 From: Department […]

Read More

UK Lords Note Medicines

Important Notice- See the Disclaimer Below Brexit Legal, McMahon Legal and Paul McMahon have no liability arising from reliance on anything contained in this article nor on this website Contact McMahon Legal  Share this article

Read More

UK Lords Note NHS and Trade Deals

Important Notice- See the Disclaimer Below Brexit Legal, McMahon Legal and Paul McMahon have no liability arising from reliance on anything contained in this article nor on this website Contact McMahon Legal  Share this article

Read More

UK Lords Note Health and Welfare

Important Notice- See the Disclaimer Below Brexit Legal, McMahon Legal and Paul McMahon have no liability arising from reliance on anything contained in this article nor on this website Contact McMahon Legal  Share this article

Read More

Medicines Regulation UK Parliament

Important Notice- See the Disclaimer Below Brexit Legal, McMahon Legal and Paul McMahon have no liability arising from reliance on anything contained in this article nor on this website Contact McMahon Legal  Share this article

Read More

EU Withdrawal Notes Medicinces

Rev 01, published on 23 January 2018 Notice to marketing authorisation holders of centrally authorised Medicinal products for human and veterinary use The United Kingdom submitted on 29 March 2017 the notification of its intention to withdraw from the Union pursuant to Article 50 of the Treaty on European Union. This means that unless a […]

Read More

Health Care Providers 2021 UK Guidance

Guidance How healthcare providers can prepare for 1 January 2021 Supply of medical products Read about the government’s plan to introduce import controls on EU goods after 31 December 2020. The government has already announced it will implement new border controls in 3 stages leading up to full implementation in July 2021. Details are set out in the Border […]

Read More

NHS Charges Overseas Visitors 2021 UK Guidance

Guidance How the NHS charges overseas visitors for NHS hospital care Updated 10 February 2020 Contents Visitors to the UK from the EEA/Switzerland People living in the EU whose healthcare costs are funded by the UK EEA and Swiss citizens resident in or moving to the UK People living outside the EEA and Switzerland Health […]

Read More

Substances Human Origin EU Guidance 2021

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Brussels, 8 June 2020 REV2 – replaces the notice (REV1) dated 23 January 2018 NOTICE TO STAKEHOLDERS WITHDRAWAL OF THE UNITED KINGDOM AND EU RULES IN THE FIELD OF SUBSTANCES OF HUMAN ORIGIN (BLOOD, TISSUES AND CELLS, ORGANS) Since 1 February 2020, the United Kingdom has withdrawn […]

Read More

Tobacco Products EU Guidance 2021

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Brussels, 8 May 2020 REV1 – replaces the notice dated 7 October 2019 NOTICE TO STAKEHOLDERS WITHDRAWAL OF THE UNITED KINGDOM AND EU RULES ON TOBACCO AND RELATED PRODUCTS Since 1 February 2020, the United Kingdom has withdrawn from the European Union and has become a “third […]

Read More

Clinical Trials EU Guidance 2021

EUROPEAN COMMISSION Directorate-General for Health and Food Safety Brussels, 7 May 2020 REV1 – replaces the notice dated 6 September 2018 NOTICE TO STAKEHOLDERS WITHDRAWAL OF THE UNITED KINGDOM AND EU RULES IN THE FIELD OF CLINICAL TRIALS Since 1 February 2020, the United Kingdom has withdrawn from the European Union and has become a […]

Read More

Healthcare Providers 2021 UK Guidance

Contents This guidance sets out the actions that healthcare providers should take to prepare for 1 January 2021. Doing this will help to plan for and manage potential service disruption to healthcare. This guidance is for commissioners and healthcare providers, including hospitals, care homes, GP practices and community pharmacies. You can also see guidance for adult […]

Read More

Drug Precursors Trade 2021 UK Guidance

Overview Drug precursor chemicals are controlled by the Home Office because they can be used to produce illicit drugs. They can also have legitimate commercial uses. You’ll need to apply for an import and/or export licence when trading with EU countries in certain categories of drug precursor chemicals from 1 January 2021. Current rules for […]

Read More